| dc.contributor.author | Fineberg, Naomi | |
| dc.contributor.author | Haddad, Peter M. | |
| dc.contributor.author | Carpenter, Lewis | |
| dc.contributor.author | Gannon, Brenda | |
| dc.contributor.author | Sharpe, Rachel | |
| dc.contributor.author | Young, Allan H. | |
| dc.contributor.author | Joyce, Eileen | |
| dc.contributor.author | Rowe, James | |
| dc.contributor.author | Wellsted, D. | |
| dc.contributor.author | Nutt, David J. | |
| dc.contributor.author | Sahakian, Barbara J. | |
| dc.date.accessioned | 2013-10-17T10:00:51Z | |
| dc.date.available | 2013-10-17T10:00:51Z | |
| dc.date.issued | 2013-09 | |
| dc.identifier.citation | Fineberg , N , Haddad , P M , Carpenter , L , Gannon , B , Sharpe , R , Young , A H , Joyce , E , Rowe , J , Wellsted , D , Nutt , D J & Sahakian , B J 2013 , ' The size, burden and cost of disorders of the brain in the UK ' , Journal of Psychopharmacology , vol. 27 , no. 9 , pp. 761-70 . https://doi.org/10.1177/0269881113495118 | |
| dc.identifier.issn | 0269-8811 | |
| dc.identifier.other | ORCID: /0000-0002-2895-7838/work/31148132 | |
| dc.identifier.uri | http://hdl.handle.net/2299/11799 | |
| dc.description.abstract | Aim: The aim of this paper is to increase awareness of the prevalence and cost of psychiatric and neurological disorders (brain disorders) in the UK. Method: UK data for 18 brain disorders were extracted from a systematic review of European epidemiological data and prevalence rates and the costs of each disorder were summarized (2010 values). Results: There were approximately 45 million cases of brain disorders in the UK, with a cost of €134 billion per annum. The most prevalent were headache, anxiety disorders, sleep disorders, mood disorders and somatoform disorders. However, the five most costly disorders (€ million) were: dementia: €22,164; psychotic disorders: €16,717; mood disorders: €19,238; addiction: €11,719; anxiety disorders: €11,687. Apart from psychosis, these five disorders ranked amongst those with the lowest direct medical expenditure per subject ( | en |
| dc.format.extent | 10 | |
| dc.format.extent | 1517121 | |
| dc.language.iso | eng | |
| dc.relation.ispartof | Journal of Psychopharmacology | |
| dc.title | The size, burden and cost of disorders of the brain in the UK | en |
| dc.contributor.institution | Centre for Health Services and Clinical Research | |
| dc.contributor.institution | Department of Psychology and Sports Sciences | |
| dc.contributor.institution | School of Life and Medical Sciences | |
| dc.contributor.institution | Department of Psychology | |
| dc.contributor.institution | Health & Human Sciences Research Institute | |
| dc.contributor.institution | Centre for Lifespan and Chronic Illness Research | |
| dc.contributor.institution | Health Services and Medicine | |
| dc.contributor.institution | Applied and Practice-based Research | |
| dc.contributor.institution | Psychology | |
| dc.contributor.institution | Health and Clinical Psychology Research Group | |
| dc.contributor.institution | Behaviour Change in Health and Business | |
| dc.description.status | Peer reviewed | |
| rioxxterms.versionofrecord | 10.1177/0269881113495118 | |
| rioxxterms.type | Journal Article/Review | |
| herts.preservation.rarelyaccessed | true | |
